Items where Author is "Stummer, Walter"
 | Up a level |
Article
Zeyen, Thomas and Boehm, Laura and Paech, Daniel and Schaefer, Niklas and Tzaridis, Theophilos and Duffy, Cathrina and Nitsch, Louisa and Schneider, Matthias and Potthoff, Anna-Laura and Schneider-Rothhaar, Javen Lennard and Steinbach, Joachim Peter and Hau, Peter and Kowalski, Thomas and Seidel, Clemens and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Zeiner, Pia Susan and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Glas, Martin and Gkika, Eleni and Vatter, Hartmut and Radbruch, Alexander and Herrlinger, Ulrich and Weller, Johannes and Schaub, Christina (2025) Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide. NEURO-ONCOLOGY, 27 (2). pp. 557-566. ISSN 1522-8517, 1523-5866
Mirian, Christian and Jensen, Lasse Rehne and Juratli, Tareq A. and Maier, Andrea Daniela and Torp, Sverre H. and Shih, Helen A. and Morshed, Ramin A. and Young, Jacob S. and Magill, Stephen T. and Bertero, Luca and Stummer, Walter and Spille, Dorothee Caecilia and Brokinkel, Benjamin and Oya, Soichi and Miyawaki, Satoru and Saito, Nobuhito and Proescholdt, Martin and Kuroi, Yasuhiro and Gousias, Konstantinos and Simon, Matthias and Moliterno, Jennifer and Prat-Acin, Ricardo and Goutagny, Stephane and Prabhu, Vikram C. and Tsiang, John T. and Wach, Johannes and Gueresir, Erdem and Yamamoto, Junkoh and Kim, Young Zoon and Lee, Joo Ho and Koshy, Matthew and Perumal, Karthikeyan and Baskaya, Mustafa K. and Cannon, Donald M. and Shrieve, Dennis C. and Suh, Chang-Ok and Chang, Jong Hee and Kamenova, Maria and Straumann, Sven and Soleman, Jehuda and Eyuepoglu, Ilker Y. and Catalan, Tony and Lui, Austin and Theodosopoulos, Philip V. and Mcdermott, Michael W. and Wang, Fang and Guo, Fuyou and Goes, Pedro and de Paiva Neto, Manoel Antonio and Jamshidi, Aria and Komotar, Ricardo and Ivan, Michael and Luther, Evan and Souhami, Luis and Guiot, Marie-Christine and Csonka, Tamas and Endo, Toshiki and Barrett, Olivia Claire and Jensen, Randy and Gupta, Tejpal and Patel, Akash J. and Klisch, Tiemo J. and Kim, Jun Won and Maiuri, Francesco and Barresi, Valeria and Tabernero, Maria Dolores and Skyrman, Simon and Broechner, Anders and Bach, Mathias Jacobsen and Law, Ian and Scheie, David and Kristensen, Bjarne Winther and Munch, Tina Norgaard and Meling, Torstein and Fugleholm, Kare and Blanche, Paul and Mathiesen, Tiit (2024) The importance of considering competing risks in recurrence analysis of intracranial meningioma. JOURNAL OF NEURO-ONCOLOGY, 166 (3). pp. 503-511. ISSN 0167-594X, 1573-7373
Zeyen, Thomas and Paech, Daniel and Weller, Johannes and Schaefer, Niklas and Tzaridis, Theophilos and Duffy, Cathrina and Nitsch, Louisa and Schneider, Matthias and Potthoff, Anna-Laura and Steinbach, Joachim Peter and Hau, Peter and Schlegel, Uwe and Seidel, Clemens and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Zeiner, Pia Susan and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Glas, Martin and Radbruch, Alexander and Herrlinger, Ulrich and Schaub, Christina (2023) Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses. JOURNAL OF NEURO-ONCOLOGY, 164 (3). pp. 607-616. ISSN 0167-594X, 1573-7373
Weller, Johannes and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Brehmer, Stefanie and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Kebir, Sied and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2019) Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial. LANCET ONCOLOGY, 20 (10). pp. 1444-1453. ISSN 1470-2045, 1474-5488
Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim Peter and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortmann, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Kowalski, Thomas and Ringel, Florian and Schmidt-Graf, Friederike and Suchorska, Bogdana and Brehmer, Stefanie and Weyerbrock, Astrid and Renovanz, Miriam and Bullinger, Lars and Galldiks, Norbert and Vajkoczy, Peter and Misch, Martin and Vatter, Hartmut and Stuplich, Moritz and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Schaub, Christina and Stummer, Walter and Tonn, Joerg-Christian and Simon, Matthias and Keil, Vera C. and Nelles, Michael and Urbach, Horst and Coenen, Martin and Wick, Wolfgang and Weller, Michael and Fimmers, Rolf and Schmid, Matthias and Hattingen, Elke and Pietsch, Torsten and Coch, Christoph and Glas, Martin (2019) Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. LANCET, 393 (10172). pp. 678-688. ISSN 0140-6736, 1474-547X
Beier, Dagmar and Proescholdt, Martin and Reinert, Christiane and Pietsch, Torsten and Jones, David T. W. and Pfister, Stefan M. and Hattingen, Elke and Seidel, Clemens and Dirven, Linda and Luerding, Ralf and Reijneveld, Jaap and Warmuth-Metz, Monika and Bonsanto, Matteo and Bremer, Michael and Combs, Stephanie E. and Rieken, Stefan and Herrlinger, Ulrich and Kuntze, Holger and Mayer-Steinacker, Regine and Moskopp, Dag and Schneider, Thomas and Beringer, Andreas and Schlegel, Uwe and Stummer, Walter and Welker, Helmut and Weyerbrock, Astrid and Paulsen, Frank and Rutkowski, Stefan and Weller, Michael and Wick, Wolfgang and Kortmann, Rolf-Dieter and Bogdahn, Ulrich and Hau, Peter (2018) Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07). NEURO-ONCOLOGY, 20 (3). pp. 400-410. ISSN 1522-8517, 1523-5866
Schaefer, Niklas and Proescholdt, Martin and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Grauer, Oliver and Goldbrunner, Roland and Friedrich, Franziska and Rohde, veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Grau, Stefan and Haenel, Mathias and Schnell, Oliver and Krex, Dietmar and Vajkoczy, Peter and Tabatabai, Ghazaleh and Mack, Frederic and Schaub, Christina and Tzaridis, Theophilos and Niessen, Michael and Kebir, Sied and Leutgeb, Barbara and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin and Herrlinger, Ulrich (2018) Quality of life in the GLARIUS trial randomizing bevacizumab/ irinotecan versus temozolomide in newly diagnosed, MGMT-nonmethylated glioblastoma. NEURO-ONCOLOGY, 20 (7). pp. 975-985. ISSN 1522-8517, 1523-5866
Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim P. and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Schlegel, Uwe and Sabel, Michael and Ronellenfitsch, Michael W. and Uhl, Martin and Maciaczyk, Jaroslaw and Grau, Stefan and Schnell, Oliver and Haenel, Mathias and Krex, Dietmar and Vajkoczy, Peter and Gerlach, Ruediger and Kortmann, Rolf-Dieter and Mehdorn, Maximilian and Tuettenberg, Jochen and Mayer-Steinacker, Regine and Fietkau, Rainer and Brehmer, Stefanie and Mack, Frederic and Stuplich, Moritz and Kebir, Sied and Kohnen, Ralf and Dunkl, Elmar and Leutgeb, Barbara and Proescholdt, Martin and Pietsch, Torsten and Urbach, Horst and Belka, Claus and Stummer, Walter and Glas, Martin (2016) Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O-6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial. JOURNAL OF CLINICAL ONCOLOGY, 34 (14). 1611-U134. ISSN 0732-183X, 1527-7755
Dubinski, Daniel and Woelfer, Johannes and Hasselblatt, Martin and Schneider-Hohendorf, Tilman and Bogdahn, Ulrich and Stummer, Walter and Wiendl, Heinz and Grauer, Oliver M. (2016) CD4(+) T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients. NEURO-ONCOLOGY, 18 (6). pp. 807-818. ISSN 1522-8517, 1523-5866
El-Khatib, Mustafa and Tepe, Carolin and Senger, Brigitte and Dibue-Adjei, Maxine and Riemenschneider, Markus Johannes and Stummer, Walter and Steiger, Hans Jakob and Cornelius, Jan Frederick (2015) Aminolevulinic Acid-Mediated Photodynamic Therapy of Human Meningioma: An in Vitro Study on Primary Cell Lines. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 16 (5). pp. 9936-9948. ISSN 1422-0067
Stummer, Walter and Tonn, Joerg-Christian and Goetz, Claudia and Ullrich, Winfried and Stepp, Herbert and Bink, Andrea and Pietsch, Thorsten and Pichlmeier, Uwe (2014) 5-Aminolevulinic Acid-derived Tumor Fluorescence: The Diagnostic Accuracy of Visible Fluorescence Qualities as Corroborated by Spectrometry and Histology and Postoperative Imaging. NEUROSURGERY, 74 (3). pp. 310-319. ISSN 0148-396X, 1524-4040
Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Stockhammer, Florian and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): LBA2000. ISSN 0732-183X, 1527-7755
Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Stockhammer, Florian and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-nonmethylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. JOURNAL OF CLINICAL ONCOLOGY, 31 (18supp): LBA2000. ISSN 0732-183X, 1527-7755
Conference or Workshop Item
Lazaridis, Lazaros and Bumes, Elisabeth and Spille, Dorothee Cacilia and Schulz, Tim and Heider, Sina and Agkatsev, Sarina and Schmidt, Teresa and Blau, Tobias and Oster, Christoph and Feldheim, Jonas and Stummer, Walter and Kessler, Almuth Friederike and Seidel, Clemens and Grauer, Oliver and Hau, Peter and Sure, Ulrich and Keyvani, Kathy and Herrlinger, Ulrich and Kleinschnitz, Christoph and Stuschke, Martin and Herrmann, Ken and Deuschl, Cornelius and Breuer, Stella and Hattingen, Elke and Scheffler, Bjoern and Kebir, Sied and Glas, Martin (2022) CTNI-18. FIRST MULTICENTRIC REAL-LIFE EXPERIENCE WITH THE COMBINATION OF CCNU AND TEMOZOLOMIDE IN NEWLY DIAGNOSED MGMT PROMOTER METHYLATED IDH WILDTYPE GLIOBLASTOMA. In: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 16-20, 2022, Tampa Bay, FL.
Zeyen, Thomas and Paech, Daniel and Weller, Johannes and Schaefer, Niklas and Tzaridis, Theophilos and Duffy, Cathrina and Nitsch, Louisa and Schneider, Matthias and Steinbach, Joachim and Hau, Peter and Schlegel, Uwe and Seidel, Clemens and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Zeiner, Pia and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Glas, Martin and Radbruch, Alexander and Herrlinger, Ulrich and Schaub, Christina (2022) NIMG-32. POSTPROGRESSION SURVIVAL AND MRI FEATURES AT PROGRESSION IN MGMT-METHYLATED GLIOBLASTOMA FOLLOWING TEMOZOLOMIDE (TMZ) OR CCNU/TMZ THERAPY - AN ANALYSIS OF THE CETEG/NOA-09-TRIAL. In: 27th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 16-20, 2022, Tampa Bay, FL.
Other
Zeyen, Thomas and Paech, Daniel and Weller, Johannes and Schaefer, Niklas and Tzaridis, Theophilos and Duffy, Cathrina and Nitsch, Louisa and Schneider, Matthias and Potthoff, Anna-Laura and Steinbach, Joachim Peter and Hau, Peter and Schlegel, Uwe and Seidel, Clemens and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Zeiner, Pia Susan and Tabatabai, Ghazaleh and Galldiks, Norbert and Stummer, Walter and Hattingen, Elke and Glas, Martin and Radbruch, Alexander and Herrlinger, Ulrich and Schaub, Christina (2023) Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses (vol 164, pg 607, 2023). SPRINGER, NEW YORK.
Franceschi, Enrico and Hofer, Silvia and Brandes, Alba A. and Frappaz, Didier and Kortmann, Rolf-Dieter and Bromberg, Jacoline and Dangouloff-Ros, Volodia and Boddaert, Nathalie and Hattingen, Elke and Wiestler, Benedikt and Clifford, Steven C. and Figarella-Branger, Dominique and Giangaspero, Felice and Haberler, Christine and Pietsch, Torsten and Pajtler, Kristian W. and Pfister, Stefan M. and Guzman, Raphael and Stummer, Walter and Combs, Stephanie E. and Seidel, Clemens and Beier, Dagmar and McCabe, Martin G. and Grotzer, Michael and Laigle-Donadey, Florence and Stucklin, Ana S. Guerreiro and Idbaih, Ahmed and Preusser, Matthias and van den Bent, Martin and Weller, Michael and Hau, Peter (2019) EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. ELSEVIER SCIENCE INC, NEW YORK.
Weller, Johannes and Tzaridis, Theophilos and Steinbach, Joachim and Schlegel, Uwe and Hau, Peter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Baehr, Oliver and Uhl, Martin and Seidel, Clemens and Tabatabai, Ghazaleh and Bullinger, Lars and Galldiks, Norbert and Schaub, Christina and Stummer, Walter and Simon, Matthias and Fimmers, Rolf and Matthias, Schmid and Coch, Christoph and Glas, Martin and Herrlinger, Ulrich and Schaefer, Niklas (2018) QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA. OXFORD UNIV PRESS INC, CARY.
Kebir, Sied and Stummer, Walter and Steinbach, Joachim and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Proescholdt, Martin and Vatter, Hartmut and Herrlinger, Ulrich and Glas, Martin (2017) COMPLETE RESECTION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN MGMT NON-METHYLATED GLIOBLASTOMA: RESULTS FROM THE GLARIUS TRIAL. OXFORD UNIV PRESS INC, CARY.
Herrlinger, Ulrich and Tzaridis, Theophilos and Mack, Frederic and Steinbach, Joachim and Schlegel, Uwe and Sabel, Michael and Hau, Peter and Kortman, Rolf-Dieter and Krex, Dietmar and Grauer, Oliver and Goldbrunner, Roland and Schnell, Oliver and Baehr, Oliver and Uhl, Martin and Tabatabai, Ghazaleh and Ringel, Florian and Schmidt-Graf, Friederike and Brehmer, Stefanie and Weyerbrock, Astrid and Bullinger, Lars and Vajkoczy, Peter and Vatter, Hartmut and Schaefer, Niklas and Kebir, Sied and Weller, Johannes and Stummer, Walter and Simon, Matthias and Keil, Vera and Nelles, Michael and Fimmers, Rolf and Pietsch, Torsten and Hattingen, Elke and Coch, Christoph and Glas, Martin (2017) PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial. OXFORD UNIV PRESS INC, CARY.
Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Kohnen, Ralf and Urbach, Horst and Stummer, Walter and Glas, Martin (2014) QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS. OXFORD UNIV PRESS INC, CARY.
Herrlinger, Ulrich and Schaefer, Nildas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Rohde, Veit and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Gies, Martin (2014) Survival and quality of life in the randomized, multicenter GLARIUS trial investigating bevacizumab/irinotecan versus standard temozolornide in newly diagnosed, MGMT-non-methylated glioblastoma patients. AMER SOC CLINICAL ONCOLOGY, ALEXANDRIA.
Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim and Weyerbrock, Anja and Hau, Peter and Goldbrunner, Roland and Kohnen, Ralf and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) BEVACIZUMAB, IRINOTECAN AND RADIOTHERAPY VERSUS STANDARD TEMOZOLOMIDE AND RADIOTHERAPY IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS: UPDATED RESULTS FROM THE RANDOMIZED MULTICENTER GLARIUS TRIAL. OXFORD UNIV PRESS INC, CARY.
